Cardinal Health

Cardinal Health and Deep Lens Collaborate for AI-based Oncology Clinical Trial Matching

by Nile
April 7, 2021

What You Should Know: – Today, Deep Lens and Cardinal Health announced a strategic collaboration that will integrate Deep Lens’ AI-based clinical trial matching solution, VIPER, into community-based oncology practices throughout the Cardinal network. VIPER will be a part of Cardinal Health’s new Navista advanced… Read More »Cardinal Health and Deep Lens Collaborate for AI-based Oncology Clinical Trial Matching

PharmaShots Weekly Snapshots (Mar 15 – 19, 2021)

by Nile
March 19, 2021

Takeda Collaborates with Anima to Discover and Develop mRNA Translation Modulators for Neurological Diseases Published: Mar 19, 2021 | Tags: Takeda, Collaborates, Anima, Discover, Develop, mRNA Translation Modulators, Neurological Diseases Kiniksa’s Arcalyst (rilonacept) Receives the US FDA’s Approval for the Treatment of Pericarditis Published: Mar… Read More »PharmaShots Weekly Snapshots (Mar 15 – 19, 2021)

PharmaShots Weekly Snapshots (Mar 15 – 19, 2021)

by Nile
March 19, 2021

Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B

by Nile
March 15, 2021

Shots: Cardinal Health signed an agreement to divest its Cordis medical device business to H&F for ~ $1B including liabilities and working capital accounts. The transaction is expected to close in the H1’ 22 Following the completion of the agreement, H&F will assume most of… Read More »Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B

Healthcare PE Firm Heritage Group Launches $317M Health Tech Fund

by Nile
January 14, 2021

Partners David McClellan, Rock Morphis, Paul Wallace (Left to Right) What You Should Know: – Healthcare private equity firm Heritage Group launches a $300M fund to invest in high-growth healthcare services and technology companies. – Heritage is backed by some of the leading healthcare organizations… Read More »Healthcare PE Firm Heritage Group Launches $317M Health Tech Fund